Nanocarriers for Inner Ear Disease Therapy

Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be us...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiaoxiang Xu, Jianwei Zheng, Yanze He, Kun Lin, Shuang Li, Ya Zhang, Peng Song, Yuye Zhou, Xiong Chen
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	nanocarrier drug delivery system inner ear disease therapy soft material nanoparticle inorganic nanoparticle Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Acceso en línea:	https://doaj.org/article/23b4ef78cb484009af99d352434b29b0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:23b4ef78cb484009af99d352434b29b0
record_format	dspace
spelling	oai:doaj.org-article:23b4ef78cb484009af99d352434b29b02021-12-03T04:56:38ZNanocarriers for Inner Ear Disease Therapy1662-510210.3389/fncel.2021.791573https://doaj.org/article/23b4ef78cb484009af99d352434b29b02021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fncel.2021.791573/fullhttps://doaj.org/toc/1662-5102Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be used for inner ear disease therapy, but there are still some drawbacks. As nanotechnology is developing these years, one of the solutions is to develop nanoparticle-based delivery systems for inner ear disease therapy. Various nanoparticles, such as soft material and inorganic-based nanoparticles, have been designed, tested, and showed controlled delivery of drugs, improved targeting property to specific cells, and reduced systemic side effects. In this review, we summarized recent progress in nanocarriers for inner ear disease therapy. This review provides useful information on developing promising nanocarriers for the efficient treatment of inner ear diseases and for further clinical applications for inner ear disease therapy.Xiaoxiang XuXiaoxiang XuJianwei ZhengYanze HeKun LinShuang LiYa ZhangPeng SongYuye ZhouYuye ZhouXiong ChenFrontiers Media S.A.articlenanocarrierdrug delivery systeminner ear disease therapysoft material nanoparticleinorganic nanoparticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENFrontiers in Cellular Neuroscience, Vol 15 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	nanocarrier drug delivery system inner ear disease therapy soft material nanoparticle inorganic nanoparticle Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
spellingShingle	nanocarrier drug delivery system inner ear disease therapy soft material nanoparticle inorganic nanoparticle Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Xiaoxiang Xu Xiaoxiang Xu Jianwei Zheng Yanze He Kun Lin Shuang Li Ya Zhang Peng Song Yuye Zhou Yuye Zhou Xiong Chen Nanocarriers for Inner Ear Disease Therapy
description	Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be used for inner ear disease therapy, but there are still some drawbacks. As nanotechnology is developing these years, one of the solutions is to develop nanoparticle-based delivery systems for inner ear disease therapy. Various nanoparticles, such as soft material and inorganic-based nanoparticles, have been designed, tested, and showed controlled delivery of drugs, improved targeting property to specific cells, and reduced systemic side effects. In this review, we summarized recent progress in nanocarriers for inner ear disease therapy. This review provides useful information on developing promising nanocarriers for the efficient treatment of inner ear diseases and for further clinical applications for inner ear disease therapy.
format	article
author	Xiaoxiang Xu Xiaoxiang Xu Jianwei Zheng Yanze He Kun Lin Shuang Li Ya Zhang Peng Song Yuye Zhou Yuye Zhou Xiong Chen
author_facet	Xiaoxiang Xu Xiaoxiang Xu Jianwei Zheng Yanze He Kun Lin Shuang Li Ya Zhang Peng Song Yuye Zhou Yuye Zhou Xiong Chen
author_sort	Xiaoxiang Xu
title	Nanocarriers for Inner Ear Disease Therapy
title_short	Nanocarriers for Inner Ear Disease Therapy
title_full	Nanocarriers for Inner Ear Disease Therapy
title_fullStr	Nanocarriers for Inner Ear Disease Therapy
title_full_unstemmed	Nanocarriers for Inner Ear Disease Therapy
title_sort	nanocarriers for inner ear disease therapy
publisher	Frontiers Media S.A.
publishDate	2021
url	https://doaj.org/article/23b4ef78cb484009af99d352434b29b0
work_keys_str_mv	AT xiaoxiangxu nanocarriersforinnereardiseasetherapy AT xiaoxiangxu nanocarriersforinnereardiseasetherapy AT jianweizheng nanocarriersforinnereardiseasetherapy AT yanzehe nanocarriersforinnereardiseasetherapy AT kunlin nanocarriersforinnereardiseasetherapy AT shuangli nanocarriersforinnereardiseasetherapy AT yazhang nanocarriersforinnereardiseasetherapy AT pengsong nanocarriersforinnereardiseasetherapy AT yuyezhou nanocarriersforinnereardiseasetherapy AT yuyezhou nanocarriersforinnereardiseasetherapy AT xiongchen nanocarriersforinnereardiseasetherapy
_version_	1718373920003850240

Nanocarriers for Inner Ear Disease Therapy

Ejemplares similares